This Friday, about 60 patients, mostly women, waited outside the clinic by mid-afternoon, many punctuating the corridor with ...
This Friday, about 60 patients, mostly women, waited outside the clinic by mid-afternoon, many punctuating the corridor with ...
At a national conference in Patna, specialists highlighted a troubling trend: women are increasingly suffering from COPD. The ...
Significant unmet needs among people with RA-ILD have been identified in a recent survey, with clear gaps in the services ...
A meta-analysis identifies immunosuppression and chronic kidney disease as carrying the highest risk for invasive ...
The Nation UAE on MSN
Respiratory infections rise in Karachi amid poor air quality
The city has seen a dramatic increase in cases of respiratory infections with the onset of winter, health experts shared, ...
Arquitos Capital Management, an investment management firm, released its third-quarter 2025 investor letter. A copy of the ...
Biohaven Ltd. (NYSE: BHVN) announced today that it presented clinical safety and efficacy data for BHV-1510 at the 2025 ...
Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat ...
The 2025 ERS Congress highlighted the emerging challenges and innovations reshaping respiratory medicine, as Ravijyot Saggu ...
Nerandomilast is an oral, preferential PDE4B inhibitor approved in China for the treatment of adult patients with IPF and PPF. It was also approved by the U.S. Food and Drug Administration (FDA) for ...
The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years.PPF is a rare lung condition, more life-threatening than many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback